Methods for evaluating variability in human health dose–response characterization

References

• AAAS. 2018. Science Journals: editorial policy. Available from: http://www.sciencemag.org/authors/science-journals-editorial-policies [accessed 11 June 2018]
   Google Scholar
• Abdel-Megeed MA, Suh DH, and Abdel-Rahman MS. 2001. Intra-species extrapolation in risk assessment of different classes of antimicrobials. Hum Ecol Risk Assess 7:15–36
   Web of Science ®Google Scholar
• Abdo N, Wetmore BA, Chappell GA, et al. 2015. In vitro screening for population variability in toxicity of pesticide-containing mixtures. Environ Int 85:147–55
   PubMed Web of Science ®Google Scholar
• Abdo N, Xia M, Brown CC, et al. 2015. Population-based in vitro hazard and concentration-response assessment of chemicals: The 1000 Genomes high-throughput screening study. Environ Health Perspect 123:458–66
   PubMed Web of Science ®Google Scholar
• Bateson TF, and Schwartz J. 2004. Who is sensitive to the effects of particulate air pollution on mortality? A case-crossover analysis of effect modifiers. Epidemiology 15:143–9
   PubMed Web of Science ®Google Scholar
• Bell ML, Zanobetti A, and Dominici F. 2013. Evidence on vulnerability and susceptibility to health risks associated with short-term exposure to particulate matter: A systematic review and meta-analysis. Am J Epidemiol 178:865–76
   PubMed Web of Science ®Google Scholar
• Bind MA, Coull BA, Peters A, et al. 2015. Beyond the mean: Quantile regression to explore the association of air pollution with gene-specific methylation in the Normative Aging Study. Environ Health Perspect 123:759–65.
   PubMed Web of Science ®Google Scholar
• Bogue MA, Churchill GA, and Chesler EJ. 2015. Collaborative cross and diversity outbred data resources in the Mouse Phenome Database. Mamm Genome 26:511–20.
   PubMed Web of Science ®Google Scholar
• Brennand KJ, Simone A, Jou J, et al. 2011. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221–5.
   PubMed Web of Science ®Google Scholar
• Burns CJ, Wright JM, Pierson JB, et al. 2014. Evaluating uncertainty to strengthen epidemiologic data for use in human health risk assessments. Environ Health Perspect 122:1160–5.
   PubMed Web of Science ®Google Scholar
• Carmichael J, DeGraff WG, Gazdar AF, et al. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936–42.
   PubMed Web of Science ®Google Scholar
• Chiu WA, Wright FA, and Rusyn I. 2017. A tiered, Bayesian approach to estimating of population variability for regulatory decision-making. ALTEX 34:377–88
   PubMedGoogle Scholar
• Choy E, Yelensky R, Bonakdar S, et al. 2008. Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines. PLoS Genet 4:e1000287.
   PubMed Web of Science ®Google Scholar
• Church RJ, Gatti DM, Urban TJ, et al. 2015. Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. Food Chem Toxicol 76:19–26.
   PubMed Web of Science ®Google Scholar
• Churchill G, Gatti D, Munger S, et al. 2012. The diversity outbred mouse population. Mamm Genome 23:713–8.
   PubMed Web of Science ®Google Scholar
• Dorne JL. 2007. Human variability in hepatic and renal elimination: Implications for risk assessment. J Appl Toxicol 27:411–20
   PubMed Web of Science ®Google Scholar
• Dourson ML, Felter SP, and Robinson D. 1996. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol 24:108–20
   PubMed Web of Science ®Google Scholar
• Dourson ML, and Stara JF. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol 3:224–38
   PubMedGoogle Scholar
• Dubowsky SD, Suh H, Schwartz J, et al. 2006. Diabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic inflammation. Environ Health Perspect 114:992–8.
   PubMed Web of Science ®Google Scholar
• Evans JS, Rhomberg LR, Williams PL, et al. 2001. Reproductive and developmental risks from ethylene oxide: A probabilistic characterization of possible regulatory thresholds. Risk Anal 21:697–718.
   PubMed Web of Science ®Google Scholar
• Evans WE, and Relling MV. 1999. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487–91
   PubMed Web of Science ®Google Scholar
• French JE, Gatti DM, Morgan DL, et al. 2015. Diversity outbred mice identify population-based exposure thresholds and genetic factors that influence benzene-induced genotoxicity. Environ Health Perspect 123:237–45.
   PubMed Web of Science ®Google Scholar
• Harrill A, Borghoff S, Zorrilla L, et al. 2017. NTP research report on baseline characteristics of diversity outbred (J:DO) mice relevant to toxicology studies. NTP Research Report 6, Research Triangle Park, NC.
   Google Scholar
• Harrill AH, and McAllister KA. 2017. New rodent population models may inform human health risk assessment and identification of genetic susceptibility to environmental exposures. Environ Health Perspect 125:086002
   PubMed Web of Science ®Google Scholar
• Harrill AH, Ross PK, Gatti DM, et al. 2009. Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel. Toxicol Sci 110:235–43
   PubMed Web of Science ®Google Scholar
• Harrill AH, Watkins PB, Su S, et al. 2009. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res 19:1507–15
   PubMed Web of Science ®Google Scholar
• Hartung T, and Daston G. 2009. Are in vitro tests suitable for regulatory use? Toxicol Sci 111:233–7
   PubMed Web of Science ®Google Scholar
• Hattis D. 2013. Human interindividual variability in parameters related to susceptibility for toxic effects [website]. Available from: http://www2.clarku.edu/faculty/dhattis [accessed 30 April 2014]
   Google Scholar
• Hattis D, Baird S, and Goble R. 2002. A straw man proposal for a quantitative definition of the RfD. Drug Chem Toxicol 25:403–36
   PubMed Web of Science ®Google Scholar
• Hattis D, Erdreich L, and Ballew M. 1987. Human variability in susceptibility to toxic chemicals—A preliminary analysis of pharmacokinetic data from normal volunteers. Risk Anal 7:415–26
   PubMed Web of Science ®Google Scholar
• Hattis D, and Lynch MK. 2007a. Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans—Implications for the derivation of single-point component uncertainty factors providing equivalent protection as existing reference doses. In: Lipscomb JC and Ohanian EV (eds), Toxicokinetics in Risk Assessment, pp. 69–93. Informa Healthcare USA, Inc., New York, NY.
   Google Scholar
• Hattis D, and Lynch MK. 2007b. Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans—Implications for the derivation of single point component uncertainty factors providing equivalent protection as existing RfDs (manuscript version). Available from: http://www2.clarku.edu/faculty/dhattis/ [accessed 16 April 2018]
   Google Scholar
• Hill AJ, Teraoka H, Heideman W, et al. 2005. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86:6–19.
   PubMed Web of Science ®Google Scholar
• Huangfu D, Osafune K, Maehr R, et al. 2008. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269–75.
   PubMed Web of Science ®Google Scholar
• Imai K, Keele L, and Tingley D. 2010. A general approach to causal mediation analysis. Psychol Methods 15:309–34
   PubMed Web of Science ®Google Scholar
• Kameoka S, Babiarz J, Kolaja K, et al. 2014. A high-throughput screen for teratogens using human pluripotent stem cells. Toxicol Sci 137:76–90.
   PubMed Web of Science ®Google Scholar
• Kang E, Wang X, Tippner-Hedges R, et al. 2016. Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs. Cell Stem Cell 18:625–36.
   PubMed Web of Science ®Google Scholar
• Kavlock R, Chandler K, Houck K, et al. 2012. Update on EPA's ToxCast program: Providing high throughput decision support tools for chemical risk management. Chem Res Toxicol 25:1287–302.
   PubMed Web of Science ®Google Scholar
• Koturbash I, Scherhag A, Sorrentino J, et al. 2011. Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene. Toxicol Sci 122:448–56.
   PubMed Web of Science ®Google Scholar
• Lapasset L, Milhavet O, Prieur A, et al. 2011. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 25:2248–53.
   PubMed Web of Science ®Google Scholar
• Lehman AJ, and Fitzhugh OG. 1954. 100-fold margin of safety. Assoc Food Drug Officials US Quart Bulletin 18:33–5
   Google Scholar
• Lipscomb JC, Teuschler LK, Swartout J, et al. 2003. The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans. Risk Anal 23:1221–38.
   PubMed Web of Science ®Google Scholar
• Lock EF, Abdo N, Huang R, et al. 2012. Quantitative high-throughput screening for chemical toxicity in a population-based in vitro model. Toxicol Sci 126:578–88.
   PubMed Web of Science ®Google Scholar
• Loomis D, and Kromhout H. 2004. Exposure variability: Concepts and applications in occupational epidemiology. Am J Ind Med 45:113–22
   PubMed Web of Science ®Google Scholar
• Maclure M. 1991. The case-crossover design: A method for studying transient effects on the risk of acute events. Am J Epidemiol 133:144–53
   PubMed Web of Science ®Google Scholar
• Mann DA. 2015. Human induced pluripotent stem cell-derived hepatocytes for toxicology testing. Expert Opin Drug Metab Toxicol 11:1–5
   PubMed Web of Science ®Google Scholar
• McNally K, Cotton R, Hogg A, et al. 2014. PopGen: A virtual human population generator. Toxicology 315:70–85.
   PubMed Web of Science ®Google Scholar
• Morimoto LM, White E, and Newcomb PA. 2003. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 158:259–63
   PubMed Web of Science ®Google Scholar
• NASEM. 2017. Controlled human inhalation-exposure studies at EPA. The National Academies Press, Washington, DC
   Google Scholar
• NASEM. 2018. Environmental chemicals, the human microbiome, and health risk: A research strategy. The National Academies Press, Washington, DC
   Google Scholar
• Naumova EN, Must A, and Laird NM. 2001. Tutorial in Biostatistics: Evaluating the impact of ‘critical periods’ in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol 30:1332–41
   PubMed Web of Science ®Google Scholar
• NIH. 2018. NIH data sharing repositories. Available from: https://www.nlm.nih.gov/NIHbmic/nih_data_sharing_repositories.html [accessed 11 June 2018]
   Google Scholar
• NRC. 2004. Intentional human dosing studies for EPA regulatory purposes: Scientific and ethical issues. The National Academies Press, Washington, DC.
   Google Scholar
• NRC. 2009. Science and decisions: Advancing risk assessment. The National Academies Press, Washington, DC.
   Google Scholar
• O’Shea SH, Schwarz J, Kosyk O, et al. 2011. In vitro screening for population variability in chemical toxicity. Toxicol Sci 119:398–407.
   PubMed Web of Science ®Google Scholar
• Park SJ, Jeong SY, and Kim HJ. 2006. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Cancer Genet Cytogenet 166:56–64
   PubMedGoogle Scholar
• Renwick AG, and Lazarus NR. 1998. Human variability and noncancer risk assessment—An analysis of the default uncertainty factor. Regul Toxicol Pharmacol 27:3–20
   PubMed Web of Science ®Google Scholar
• Richiardi L, Bellocco R, and Zugna D. 2013. Mediation analysis in epidemiology: Methods, interpretation and bias. Int J Epidemiol 42:1511–9
   PubMed Web of Science ®Google Scholar
• Ring CL, Pearce RG, Setzer RW, et al. 2017. Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability. Environ Int 106:105–18.
   PubMed Web of Science ®Google Scholar
• Rotroff DM, Wetmore BA, Dix DJ, et al. 2010. Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicol Sci 117:348–58.
   PubMed Web of Science ®Google Scholar
• Rusyn I, Gatti DM, Wiltshire T, et al. 2010. Toxicogenetics: Population-based testing of drug and chemical safety in mouse models. Pharmacogenomics 11:1127–36.
   PubMed Web of Science ®Google Scholar
• Scholz G, Pohl I, Genschow E, et al. 1999. Embryotoxicity screening using embryonic stem cells in vitro: Correlation to in vivo teratogenicity. Cells Tissues Organs (Print) 165:203–11.
   PubMed Web of Science ®Google Scholar
• Schwartz J. 2015. Identifying susceptibility in epidemiology studies: Implications for risk assessment. Available from: http://nas-sites.org/emergingscience/files/2015/10/Schwartz_Presentation.pdf [accessed 24 April 2019]
   Google Scholar
• Schwartz J, Bellinger D, and Glass T. 2011. Expanding the scope of risk assessment: Methods of studying differential vulnerability and susceptibility. Am J Public Health 101:S102–S9
   PubMed Web of Science ®Google Scholar
• Schwartz J, Litonjua A, Suh H, et al. 2005. Traffic related pollution and heart rate variability in a panel of elderly subjects. Thorax 60:455–61.
   PubMed Web of Science ®Google Scholar
• Scoville DK, White CC, Botta D, et al. 2015. Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains. Toxicol Appl Pharmacol 289:240–50.
   PubMed Web of Science ®Google Scholar
• Sexton K, and Hattis D. 2007. Assessing cumulative health risks from exposure to environmental mixtures—Three fundamental questions. Environ Health Perspect 115:825–32
   PubMed Web of Science ®Google Scholar
• Shorter JR, Odet F, Aylor DL, et al. 2017. Male infertility is responsible for nearly half of the extinction observed in the mouse collaborative cross. Genetics 206:557–72.
   PubMed Web of Science ®Google Scholar
• Si-Tayeb K, Noto FK, Nagaoka M, et al. 2010. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297–305.
   PubMed Web of Science ®Google Scholar
• Simoni M, Baldacci S, Maio S, et al. 2015. Adverse effects of outdoor pollution in the elderly. J Thorac Dis 7:34–45.
   PubMed Web of Science ®Google Scholar
• Skowronski GA, and Abdel-Rahman MS. 2001. Relevance of the 10X uncertainty factor to the risk assessment of drugs used by children and geriatrics. Hum Ecol Risk Assess 7:139–52
   Web of Science ®Google Scholar
• Studer L, Vera E, and Cornacchia D. 2015. Programming and reprogramming cellular age in the era of induced pluripotency. Cell Stem Cell 16:591–600
   PubMed Web of Science ®Google Scholar
• Swartout JC, Price PS, Dourson ML, et al. 1998. A probabilistic framework for the reference dose (probabilistic RfD). Risk Anal 18:271–82.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–72.
   PubMed Web of Science ®Google Scholar
• Tan YM, Worley RR, Leonard JA, et al. 2018. Challenges associated with applying physiologically based pharmacokinetic modeling for public health decision-making. Toxicol Sci 162:341–8.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Sonawane B, Barton HA, et al. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health B Crit Rev 11:519–47.
   PubMed Web of Science ®Google Scholar
• Threadgill DW, and Churchill GA. 2012. Ten years of the collaborative cross. G3 (Bethesda) 2:153–6
   PubMedGoogle Scholar
• Threadgill DW, Miller DR, Churchill GA, et al. 2011. The Collaborative Cross: A recombinant inbred mouse population for the systems genetic era. ILAR J 52:24–31.
   PubMed Web of Science ®Google Scholar
• U.S. EPA. 2001. Toxicological review of methylmercury in support of summary information on integrated risk information (IRIS). Washington, DC.
   Google Scholar
• U.S. EPA. 2002. A review of the reference dose and reference concentration processes. EPA/630/P-02/002F. Washington, DC.
   Google Scholar
• U.S. EPA. 2004. Toxicological review of boron and compounds in support of summary information on integrated risk information (IRIS). Washington, DC.
   Google Scholar
• U.S. EPA. 2009. Integrated science assessment for particulate matter (Final report). EPA/600/R-08/139F. Washington, DC.
   Google Scholar
• U.S. EPA. 2011a. Toxicological review of dichloromethane in support of summary information on integrated risk information (IRIS). Washington, DC.
   Google Scholar
• U.S. EPA. 2011b. Toxicological review of trichloroethylene in support of summary information on integrated risk information (IRIS). Washington, DC.
   Google Scholar
• U.S. EPA. 2013a. Integrated science assessment for lead. EPA/600/R-10/075F. Research Triangle Park, NC.
   Google Scholar
• U.S. EPA. 2013b. Integrated science assessment for ozone and related photochemical oxidants. EPA/600/R-10/076F. Research Triangle Park, NC.
   Google Scholar
• U.S. EPA. 2014. Guidance for applying quantitative data to develop data-derived extrapolation factors for interspecies and intraspecies extrapolation. EPA/R-14/002, Washington, DC.
   Google Scholar
• U.S. EPA. 2016a. Integrated science assessment for oxides of Nitrogen—Health Criteria. EPA/600/R-15/068, Research Triangle Park, NC.
   Google Scholar
• U.S. EPA. 2016b. Plan to increase access to results of EPA-funded scientific research. 601-R-16-005.
   Google Scholar
• U.S. EPA. 2017. Integrated science assessment (ISA) for sulfur oxides—Health Criteria (Final). EPA/600/R-17/451. Washington, DC.
   Google Scholar
• U.S. EPA. 2018. Basic information about the integrated risk information system. Available from: https://www.epa.gov/iris/basic-information-about-integrated-risk-information-system [accessed 26 April 2018]
   Google Scholar
• UNC Systems Genetics 2018. CC mice—Available strains. Available from: http://csbio.unc.edu/CCstatus/index.py?run=availableLines [accessed 5 June 2018]
   Google Scholar
• Van de Wiele T, Vanhaecke L, Boeckaert C, et al. 2005. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ Health Perspect 113:6–10.
   PubMed Web of Science ®Google Scholar
• Vichai V, and Kirtikara K. 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1:1112–6
   PubMed Web of Science ®Google Scholar
• West PR, Weir AM, Smith AM, et al. 2010. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol 247:18–27.
   PubMed Web of Science ®Google Scholar
• Wetmore BA, Allen B, Clewell HJ, 3rd, et al. 2014. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing. Toxicol Sci 142:210–24.
   PubMed Web of Science ®Google Scholar
• Wetmore BA, Wambaugh JF, Ferguson SS, et al. 2012. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol Sci 125:157–74.
   PubMed Web of Science ®Google Scholar
• WHO. 2014. Guidance document on evaluating and expressing uncertainty in hazard characterization. Harmonization project document 11. WHO, Geneva, Switzerland.
   Google Scholar
• Yoo HS, Bradford BU, Kosyk O, et al. 2015a. Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects. J Toxicol Environ Health A 78:15–31
   PubMed Web of Science ®Google Scholar
• Yoo HS, Bradford BU, Kosyk O, et al. 2015b. Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: Kidney effects. J Toxicol Environ Health A 78:32–49
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–20.
   PubMed Web of Science ®Google Scholar
• Zeise L, Bois FY, Chiu WA, et al. 2013. Addressing human variability in next-generation human health risk assessments of environmental chemicals. Environ Health Perspect 121:23–31.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wilson GF, Soerens AG, et al. 2009. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30–41.
   PubMed Web of Science ®Google Scholar